HIKALNSEHikal Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 3 Dec, 2025 · 18:57 IST

Promoter group firms amalgamated into Castilia Life Sciences

HIKAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.2%Reaction day
₹254.00
prior close
₹248.49
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%+0.3% vs market
Pharmaceuticals peers, median of 156sector-0.2%-0.1% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+1.9
10m
+2.5
15m
+1.7
30m
+1.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.2-0.5+0.3-0.2-0.1
Next day
-5.0-1.7-3.4-0.5-4.5
2d
-7.9-4.0-3.9-2.6-5.3
3d
-7.3-2.1-5.2-1.8-5.5
4d
-0.6-2.7+2.1-2.0+1.5
5d
-0.8-2.3+1.5-1.2+0.4
1w
-1.4-1.5+0.2-0.7-0.7
15d
-8.2-1.8-6.4-1.3-6.9
1m
-11.5+0.1-11.6-0.3-11.2
2m
-22.8-3.3-19.5-5.5-17.3
3m
-27.2-11.2-16.0-10.2-16.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Two promoter group entities - Shri Rameshwara Investment and Shri Badrinath Investment - have merged into Castilia Life Sciences, also a promoter group firm. The composite scheme was approved by the Regional Director (Western Region, Mumbai) on November 18, 2025 and made effective on December 3, 2025. Consequently, the Hikal shares held by the two merged entities have now vested with Castilia.

Likely market impact

Internal promoter group consolidation only. No change in public shareholding, business, or operations. Neutral for minority shareholders.